References
- Tegtmeyer LC, Rust S, van Scherpenzeel M, Ng BG, Losfeld ME, Timal S, et al. Multiple phenotypes in phosphoglucomutase 1 deficiency. N Engl J Med. 2014;370(6):533–542.10.1056/NEJMoa1206605
- Funke S, Gardeitchik A, Kouwenberg D, Mohamed M, Wormann S, Korsch E, et al. Perinatal and early infantile symptoms in congenital disorders of glycosylation. Am J Med Genet A. 2013;161(3):578–584.10.1002/ajmg.a.v161.3
- Preisler N, Laforêt P, Echaniz-Laguna A, Ørngreen MC, Lonsdorfer-Wolf E, Doutreleau S, et al. Fat and carbohydrate metabolism during exercise in phosphoglucomutase type 1 deficiency. J Clin Endocrinol Metab. 2013;98(7):E1235–E1240.10.1210/jc.2013-1651
- Miller BS, Khosravi MJ, Patterson MC, Conover CA. IGF system in children with congenital disorders of glycosylation. Clin Endocrinol. 2009;70(6):892–897.10.1111/cen.2009.70.issue-6
- Morava E. Galactose supplementation in phoshoglucomutase-1 deficiency; review and outlook for a novel treatable CDG. Mol Genet Metab. 2014;112(4):275–279.10.1016/j.ymgme.2014.06.002
- Beamer LJ. Mutations in hereditary phsophoglucomutase 1 deficiency map to key regions of enzyme structure and function. J Inherit Metab Dis. 2015;38:243–256.10.1007/s10545-014-9757-9